ํธ๋ฆฌํ ๋ ๋๋ฏผ
ํธ๋ฆฌํ ๋ ๋๋ฏผ์ ์ฃผ๋ก ๋๋๋ฌผ ์์ํ์์ ์ฌ์ฉ๋๋ **1์ธ๋ ์ํธ๋ ๋์๋ฏผ๊ณ ํญํ์คํ๋ฏผ์ **์ ๋๋ค. ํ์คํ๋ฏผ ๋งค๊ฐ ์๋ ๋ฅด๊ธฐ ๋ฐ์ ๋ฐ ์๋ํ๋ฝ์์ค๋ฅผ ์ํํ๋ ๋ฐ ์ฌ์ฉ๋ฉ๋๋ค. ํฅ๋ฏธ๋กญ๊ฒ๋ '๊ธฐ๋ฆฝ๋ถ๋ฅ์ฐ ์ฆํ๊ตฐ(Downer cow syndrome)'์์ **์ค์ถ์ ๊ฒฝ๊ณ(CNS) ์๊ทน์ **๋ก ์คํ๋ผ๋ฒจ(ํ๊ฐ ์ธ)๋ก ์ฌ์ฉ๋๊ธฐ๋ ํฉ๋๋ค(์ฒ์ฒํ ์ ๋งฅ ์ฃผ์ฌ). 1์ธ๋ ํญํ์คํ๋ฏผ์ ์ด๊ธฐ ๋๋ฌธ์ ํ์ก-๋ ์ฅ๋ฒฝ(BBB)์ ์ฝ๊ฒ ํต๊ณผํ๋ฉฐ, ์ง์ ์์๋ถํฐ ์ญ์ค์ ํฅ๋ถ(ํนํ ๋ง์์)์ ์ด๋ฅด๊ธฐ๊น์ง ์ฌ๊ฐํ ์ค์ถ์ ๊ฒฝ๊ณ ์ํฅ์ ์ ๋ฐํ ์ ์์ต๋๋ค. *์์ ์์ *: ๊ธ์ฑ ์๋ ๋ฅด๊ธฐ ๋ฐ์์ ๋งค์ฐ ํจ๊ณผ์ ์ด์ง๋ง, ์ง์ ์์ฉ์ด ์ ์ ์๋ก์ด ํญํ์คํ๋ฏผ์ ๊ฐ ์ถ์๋๊ณ ๋ง์ ๊ฒฝ๊ตฌ์ฉ ํธ๋ฆฌํ ๋ ๋๋ฏผ ์ ์ ๊ฐ ๋จ์ข ๋จ์ ๋ฐ๋ผ ์๋๋ฌผ ์์์์์ ์ฌ์ฉ์ ๊ฐ์ํ์ต๋๋ค.
์์ฉ ๊ธฐ์ : Tripelennamine acts as a **competitive antagonist at the H1-receptor**. * **Histamine Release** โ Histamine binds to H1 receptors on smooth muscle, endothelium, and the CNS. * **Tripelennamine** โ Competes for these receptor sites โ Prevents histamine-induced bronchoconstriction, vasodilation, and increased capillary permeability. *Note*: Antihistamines do *not* inactivate histamine or prevent its degranulation/release from mast cells; they only block its downstream effects. Compared to other antihistamines, tripelennamine has **moderate sedative activity** and **minimal anticholinergic activity**.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- General antihistamine ยท 1 mg/kg PO q12h ยท PO ยท q12h ยท Oral dosage forms may no longer be obtainable
- General antihistamine ยท 1 mg/kg IM ยท IM
- General antihistamine ยท 1.1 mg/kg (2.5 mL per 100 lbs body weight) IV (for more immediate effect) or IM q6-12h as needed ยท IV/IM ยท q6-12h ยท as needed
- Downer Cow Syndrome (Adjunctive treatment) ยท 0.5 mg/kg slow IV in conjunction with parenteral mineral treatment ยท IV ยท Used as a CNS stimulant
- General antihistamine ยท 1 mg/kg IV or IM ยท IV/IM
- General antihistamine ยท 1.1 mg/kg (2.5 mL per 100 lbs body weight) IM q6-12h as needed ยท IM ยท q6-12h ยท as needed ยท Do NOT give IV. ARCI UCGFS Class 3 Drug.
- General antihistamine ยท 1 mg/kg IM ยท IM ยท Do NOT give IV. ARCI UCGFS Class 3 Drug.
- General antihistamine ยท 1 mg/kg IV or IM ยท IV/IM
- General antihistamine ยท 1 mg/kg PO q12h ยท PO ยท q12h ยท Oral dosage forms may no longer be obtainable
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Intravenous (IV) administration in horses is strictly contraindicated due to severe CNS stimulation
์ด์๋ฐ์
- CNS stimulation (hyperexcitability, nervousness, muscle tremors) - especially in horses given IV
- CNS depression / Sedation
- Ataxia / Incoordination
- Gastrointestinal disturbances
์ฝ๋ฌผ ์ํธ์์ฉ
- CNS Depressants (e.g., barbiturates, opioids) ยท Increased sedation and CNS depression
- Heparin ยท May partially counteract the anticoagulation effects
- Warfarin ยท May partially counteract the anticoagulation effects
๋ชจ๋ํฐ๋ง
- Clinical efficacy (resolution of allergic signs)
- Adverse effects (CNS stimulation, sedation, ataxia)
๊ณผ์ฉ๋
Overdosage of tripelennamine can cause **CNS excitation, seizures, and ataxia**. * **Treatment**: Treat symptomatically and supportively if clinical signs are severe. * **Seizure Management**: Phenytoin (IV) is recommended in the treatment of seizures caused by antihistamine overdose in humans. **Barbiturates and diazepam are generally avoided** as they may exacerbate post-excitatory CNS depression.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.